Women and Coronary Artery Disease

Clinical Trial Finder

Many women with coronary artery disease are interested in participating in the latest research regarding their condition. This Clinical Trial Finder can help you—or a loved one—easily find ongoing cardiovascular clinical research trials for which you might qualify. This list is a service of the U.S. National Institutes of Health called clinicaltrials.gov, a database of publicly and privately supported clinical studies.

Simply click on the trial below that interests you to learn how you might participate.

A Study of the ReCor Medical Paradise System in Clinical Hypertension

Conditions:   Hypertension;   Vascular Diseases
Interventions:   Device: The Paradise® Renal Denervation Ultrasound System;   Device: Sham Procedure
Sponsor:   ReCor Medical, Inc.
Recruiting - verified July 2016

The Neu-Prem Trial: Neuromonitoring of Preterm Newborn Brain During Birth Resuscitation

Conditions:   Neurologic Manifestations;   Premature Birth;   Hypoxia-Ischemia, Brain
Interventions:   Device: EEG;   Device: NIRS
Sponsors:   Sharp HealthCare;   The Gerber Foundation
Recruiting - verified July 2016

Pulmonary Artery Denervation for Treatment of Pulmonary Arterial Hypertension

Condition:   Pulmonary Arterial Hypertension
Interventions:   Procedure: denervation;   Procedure: sham procedure
Sponsors:   Centre Hospitalier Universitaire de Nice;   Assistance Publique Hopitaux De Marseille;   University Hospital, Toulouse;   University Hospital, Grenoble;   Assistance Publique - Hôpitaux de Paris
Recruiting - verified February 2016

Genomics, Environmental Factors and Social Determinants of Cardiovascular Disease in African-Americans Study (GENE-FORECAST)

Conditions:   Hypertension;   Cardiovascular Disease
Intervention:  
Sponsor:   National Human Genome Research Institute (NHGRI)
Recruiting - verified July 2016

Effects of Oral Sildenafil on Mortality in Adults With PAH

Condition:   Pulmonary Arterial Hypertension
Interventions:   Drug: sildenafil citrate;   Drug: sildenafil citrate;   Drug: sildenafil citrate
Sponsor:   Pfizer
Recruiting - verified July 2016

Identify Clinical Conditions That Increase Circulating DNA Levels

Conditions:   Pregnancy;   Pulmonary Embolism;   Myocardial Infarction;   Autoimmune Disease
Intervention:   Other: One time blood draw to look at patient's DNA
Sponsor:   University of Florida
Active, not recruiting - verified July 2016

Vest Prevention of Early Sudden Death Trial and VEST Registry

Conditions:   Myocardial Infarction;   Ventricular Dysfunction;   Sudden Death;   Ventricular Tachycardia;   Ventricular Fibrillation
Intervention:   Device: wearable defibrillator
Sponsors:   University of California, San Francisco;   Zoll Medical Corporation
Recruiting - verified July 2016

Identification of Genomic Predictors of Adverse Events After Cardiac Surgery

Conditions:   Heart; Dysfunction Postoperative, Cardiac Surgery;   Genetic Predisposition to Disease;   Atrial Fibrillation;   Myocardial Infarction;   Heart Failure
Intervention:  
Sponsors:   Brigham and Women's Hospital;   National Heart, Lung, and Blood Institute (NHLBI);   Texas Heart Institute;   University of Texas Southwestern Medical Center
Recruiting - verified July 2016

Effects of Amino Acids on Regional Lipid Metabolism

Condition:   Hypertriglyceridemia
Interventions:   Dietary Supplement: Amino acids;   Dietary Supplement: Placebo
Sponsors:   University of Arkansas;   National Institute on Aging (NIA)
Recruiting - verified July 2016

IMAGE-HF Project I-A: Cardiac Imaging in Ischemic Heart Failure (AIMI-HF)

Conditions:   Heart Failure;   Coronary Artery Disease;   Ischemic Cardiomyopathy;   Non-ischemic Cardiomyopathy
Interventions:   Other: Advanced cardiac imaging;   Other: Standard Cardiac Imaging
Sponsors:   Ottawa Heart Institute Research Corporation;   Canadian Institutes of Health Research (CIHR);   The Finnish Funding Agency for Technology and Innovation (TEKES)
Recruiting - verified July 2016

IK-1001 (Sodium Sulfide (Na2S) for Injection) in Subjects With Acute ST-Segment Elevation Myocardial Infarction

Condition:   ST-Segment Elevation Myocardial Infraction
Interventions:   Drug: Sodium Sulfide (Na2S) for Injection;   Drug: Placebo
Sponsor:   Mallinckrodt
Withdrawn - verified July 2016

Relative Risks for Non-fatal Venous Thromboembolism, Ischemic Stroke and Myocardial Infarction in Users of ORTHO EVRA(Norelgestromin and Ethinyl Estradiol Contraceptive Patch) Compared to Levonorgestrel-containing Oral Contraceptives.

Conditions:   Contraception;   Female Contraception;   Fertility Control
Intervention:  
Sponsors:   Johnson & Johnson Pharmaceutical Research & Development, L.L.C.;   Boston Collaborative Drug Surveillance Program
Completed - verified July 2016

Phenylephrine in Spinal Anesthesia in Preeclamptic Patients

Conditions:   Preeclampsia;   Hypotension
Interventions:   Drug: Ephedrine;   Drug: Phenylephrine
Sponsor:   Northwestern University
Recruiting - verified July 2016

A Postmarketing Study of the Risk of Venous Thromboembolism (Blood Clots), Myocardial Infarction (Heart Attacks), and Stroke Among Women Using ORTHO EVRA (Norelgestromin and Ethinyl Estradiol Contraceptive Patch) Compared With Women Who Take Oral Contraceptives for Birth Control

Conditions:   Contraception;   Female Contraception
Interventions:   Drug: Transdermal Contraceptive System;   Drug: Norgestimate-containing oral contraceptives with EE
Sponsor:   Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Completed - verified July 2016

Estrogen Replacement to Reduce Risk of Neurologic Injury After Coronary Artery Bypass Graft Surgery

Conditions:   Coronary Disease;   Cardiovascular Diseases;   Heart Diseases;   Neurologic Manifestations
Interventions:   Drug: Estrogen Replacement Therapy;   Procedure: Surgery
Sponsor:   National Heart, Lung, and Blood Institute (NHLBI)
Terminated - verified December 2007

Secondary Pulmonary Hypertension in Adults With Sickle Cell Anemia

Conditions:   Pulmonary Hypertension;   Sickle Cell Anemia;   Sickle Cell Disease
Intervention:  
Sponsors:   National Heart, Lung, and Blood Institute (NHLBI);   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified July 2016

Risk of Coronary Heart Disease in Women With Polycystic Ovary Syndrome

Conditions:   Atherosclerosis;   Cardiovascular Diseases;   Heart Diseases;   Carotid Artery Diseases;   Coronary Disease;   Polycystic Ovary Syndrome
Intervention:  
Sponsor:   National Heart, Lung, and Blood Institute (NHLBI)
Completed - verified January 2008

Multi-Ethnic Study of Atherosclerosis (MESA)

Conditions:   Atherosclerosis;   Cardiovascular Diseases;   Heart Diseases;   Coronary Artery Disease;   Coronary Disease;   Stroke;   Myocardial Infarction;   Heart Failure;   Diabetes Mellitus, Type 2;   Hypertension;   Diabetes Mellitus
Intervention:  
Sponsor:   National Heart, Lung, and Blood Institute (NHLBI)
Active, not recruiting - verified April 2012